| 1 |
33805130 | Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers. | 2021 Mar 24 |
1 |
| 2 |
31636356 | A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs. | 2020 Apr |
1 |
| 3 |
26876117 | Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies. | 2016 May |
2 |
| 4 |
25560469 | COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine. | 2015 Jan |
2 |
| 5 |
24423786 | Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation. | 2014 Apr |
1 |
| 6 |
24429224 | Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem. | 2014 Apr |
4 |
| 7 |
22044428 | Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. | 2012 Feb |
3 |
| 8 |
22283753 | Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia. | 2012 Jun |
1 |
| 9 |
22419526 | Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. | 2012 May |
1 |
| 10 |
19149529 | Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? | 2009 Jan |
1 |
| 11 |
18707769 | Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? | 2008 Dec 16 |
1 |
| 12 |
16697427 | QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. | 2006 Aug |
1 |
| 13 |
16918396 | Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. | 2006 Aug |
2 |
| 14 |
15358978 | A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment. | 2004 Sep |
2 |
| 15 |
12589516 | Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. | 2003 Mar |
3 |
| 16 |
12923612 | Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924. | 2003 Sep |
2 |
| 17 |
11997696 | Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action. | 2002 May 7 |
1 |
| 18 |
11163544 | Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. | 2001 Jan 15 |
2 |
| 19 |
10087034 | S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine. | 1999 Apr |
1 |
| 20 |
9732398 | S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. | 1998 Sep |
1 |
| 21 |
9369342 | 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine. | 1997 Sep 10 |
1 |
| 22 |
8684591 | Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors. | 1996 Jan |
2 |
| 23 |
1426017 | Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue. | 1992 Oct 20 |
2 |